177 related articles for article (PubMed ID: 19265130)
1. RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NF-kappa B.
Manukyan M; Nalbant P; Luxen S; Hahn KM; Knaus UG
J Immunol; 2009 Mar; 182(6):3522-9. PubMed ID: 19265130
[TBL] [Abstract][Full Text] [Related]
2. TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response.
Teixeira HS; Zhao J; Kazmierski E; Kinane DF; Benakanakere MR
Cells; 2020 Aug; 9(8):. PubMed ID: 32824595
[TBL] [Abstract][Full Text] [Related]
3. AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling.
Shibolet O; Giallourakis C; Rosenberg I; Mueller T; Xavier RJ; Podolsky DK
J Biol Chem; 2007 Nov; 282(48):35308-17. PubMed ID: 17878165
[TBL] [Abstract][Full Text] [Related]
4. The low molecular weight GTPase RhoA and atypical protein kinase Czeta are required for TLR2-mediated gene transcription.
Teusch N; Lombardo E; Eddleston J; Knaus UG
J Immunol; 2004 Jul; 173(1):507-14. PubMed ID: 15210811
[TBL] [Abstract][Full Text] [Related]
5. The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway.
Cai M; Li M; Wang K; Wang S; Lu Q; Yan J; Mossman KL; Lin R; Zheng C
PLoS One; 2013; 8(1):e54586. PubMed ID: 23382920
[TBL] [Abstract][Full Text] [Related]
6. RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Park SY; Lee SW; Lee WS; Rhim BY; Lee SJ; Kwon SM; Hong KW; Kim CD
Biochem Pharmacol; 2013 Nov; 86(9):1320-7. PubMed ID: 23973526
[TBL] [Abstract][Full Text] [Related]
7. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
9. Src-family-tyrosine kinase Lyn is critical for TLR2-mediated NF-κB activation through the PI 3-kinase signaling pathway.
Toubiana J; Rossi AL; Belaidouni N; Grimaldi D; Pene F; Chafey P; Comba B; Camoin L; Bismuth G; Claessens YE; Mira JP; Chiche JD
Innate Immun; 2015 Oct; 21(7):685-97. PubMed ID: 26055819
[TBL] [Abstract][Full Text] [Related]
10. Heterotrimeric Gi/Go proteins modulate endothelial TLR signaling independent of the MyD88-dependent pathway.
Dauphinee SM; Voelcker V; Tebaykina Z; Wong F; Karsan A
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2246-53. PubMed ID: 21949112
[TBL] [Abstract][Full Text] [Related]
11. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
12. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
[TBL] [Abstract][Full Text] [Related]
13. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
14. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.
Goto Y; Arigami T; Kitago M; Nguyen SL; Narita N; Ferrone S; Morton DL; Irie RF; Hoon DS
Mol Cancer Ther; 2008 Nov; 7(11):3642-53. PubMed ID: 19001446
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
17. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
Guo F; Zhou Z; Dou Y; Tang J; Gao C; Huan J
Cytokine; 2012 Mar; 57(3):417-28. PubMed ID: 22226621
[TBL] [Abstract][Full Text] [Related]
18. Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry.
Raghu H; Sharma-Walia N; Veettil MV; Sadagopan S; Caballero A; Sivakumar R; Varga L; Bottero V; Chandran B
J Virol; 2007 Aug; 81(15):7941-59. PubMed ID: 17507466
[TBL] [Abstract][Full Text] [Related]
19. Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection.
Luo X; Zhang R; Lu M; Liu S; Baba HA; Gerken G; Wedemeyer H; Broering R
Front Immunol; 2021; 12():684424. PubMed ID: 34113355
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
Bulut Y; Faure E; Thomas L; Equils O; Arditi M
J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
